MAX-10181

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameMAX-10181
Drug Alias NameMAX-10181MAX-1MX-10181
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed death-ligand 1 blockersProgrammed cell death protein 1 blockers
TargetsProgrammed death-ligand 1Programmed cell death protein 1
Therapy Area/IndicationsSolid tumoursGlioblastomaGlioma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesMaxiNovel Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesMaxinovel Pharmaceutical Shanghai IncMaxiNovel Pharmaceuticals Co Ltd
Inactive CompaniesMaxinovel Pty Ltd
Active IndicationsSolid tumoursGlioblastomaGlioma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A